3rd Department of Internal Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic.
Steroid Hormone Unit, Institute of Endocrinology, Prague, Czech Republic.
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3545-3556. doi: 10.1210/jc.2018-01926.
Improvement of imaging methods has led to more incidental adrenal tumor findings, especially adenomas. Routine hormonal evaluation uses only a few steroids to evaluate possible hormonal hypersecretion of these adenomas, but a wide spectrum of serum steroid hormone changes has not been published.
To measure the serum levels of 83 steroids from patients with unilateral and bilateral adrenal incidentalomas to uncover full steroid profile changes in patients with subclinical hypercortisolism (SH).
Cross-sectional study.
The study was conducted at a tertiary inpatient clinic.
Fifty-two patients with adrenal incidentalomas (unilateral, n = 29; bilateral, n = 23), including nonfunctioning (n = 11) vs SH (n = 41), and 26 age- and sex-matched controls from the general population were included.
Eighty-three serum steroids were measured by gas chromatography-tandem mass spectrometry (GC-MS/MS) before and after 1 mg dexamethasone, ACTH, midnight serum cortisol, and urinary free cortisol/24 hour.
Of 83 measured steroids, 10 were significantly decreased in patients with SH, including dehydroepiandrosterone sulfate (DHEAS), androsterone sulfate, epiandrosterone sulfate, androstenediol sulfate, conjugated 5α-androstane-3β,17β-diol, and conjugated 5α-androstane-3α,17β-diol. This finding was observed even when unilateral, bilateral, male, and female subgroups were analyzed separately. When we compared routine clinical methods and GC-MS/MS‒measured steroids, the most discriminatory was DHEAS followed by midnight serum cortisol, epiandrosterone sulfate, androsterone sulfate, ACTH, and 16α-hydroxypregnenolone.
SH was associated with decreased levels of adrenal androgens, their metabolites, and pregnenolone metabolite. GC-MS/MS is a powerful tool for measuring serum levels of these undescribed changes in steroid metabolism, which are characteristic of SH in adrenal incidentalomas.
成像方法的改进导致更多偶然发现的肾上腺肿瘤,特别是腺瘤。常规激素评估仅使用少数几种类固醇来评估这些腺瘤可能的激素过度分泌,但尚未发表广泛的血清类固醇激素变化谱。
测量单侧和双侧偶然发现的肾上腺肿瘤患者的 83 种类固醇血清水平,以揭示亚临床皮质醇增多症 (SH) 患者的完整类固醇谱变化。
横断面研究。
研究在一家三级住院诊所进行。
52 例偶然发现的肾上腺肿瘤患者(单侧,n = 29;双侧,n = 23),包括无功能(n = 11)与 SH(n = 41),以及 26 名年龄和性别匹配的普通人群对照者。
在 1 mg 地塞米松、ACTH、午夜血清皮质醇和尿游离皮质醇/24 小时之前和之后,通过气相色谱-串联质谱法 (GC-MS/MS) 测量 83 种血清类固醇。
在 83 种测量的类固醇中,10 种在 SH 患者中显著降低,包括脱氢表雄酮硫酸酯 (DHEAS)、雄酮硫酸酯、表雄酮硫酸酯、雄烯二酮硫酸酯、结合 5α-雄烷-3β,17β-二醇和结合 5α-雄烷-3α,17β-二醇。即使在分别分析单侧、双侧、男性和女性亚组时,也观察到这种发现。当我们比较常规临床方法和 GC-MS/MS 测量的类固醇时,最具鉴别力的是 DHEAS,其次是午夜血清皮质醇、表雄酮硫酸酯、雄酮硫酸酯、ACTH 和 16α-羟孕烯醇酮。
SH 与肾上腺雄激素及其代谢物和孕烯醇酮代谢物水平降低有关。GC-MS/MS 是一种强大的工具,可用于测量这些未描述的类固醇代谢变化的血清水平,这些变化是偶然发现的肾上腺肿瘤中 SH 的特征。